Key Finding
Acupuncture inhibits mast cell degranulation and modulates inflammatory pathways by suppressing NF-κB, MAPK, and TLR4/MyD88 signaling while reducing pro-inflammatory cytokines and increasing anti-inflammatory IL-10 in allergic disorders.
Allergic conditions like asthma, hay fever, and eczema occur when specialized immune cells called mast cells release chemicals that trigger inflammation, itching, sneezing, and breathing difficulties. Researchers reviewed 365 studies published between 2010 and 2025 to understand how acupuncture might help control these allergic reactions by affecting mast cell activity.
The review found that acupuncture appears to work through multiple mechanisms to reduce allergic symptoms. It helps prevent mast cells from releasing histamine and other inflammatory substances that cause allergic reactions. Acupuncture also reduced levels of IgE, an antibody associated with allergies, and decreased inflammatory proteins like TNF-alpha, IL-4, IL-5, and IL-13 while increasing anti-inflammatory IL-10. These changes occurred by blocking specific inflammatory pathways in the body, including NF-kB, MAPK, and TLR4/MyD88.
In clinical studies with patients, acupuncture improved lung function measurements in asthma sufferers, showing better FEV1 and peak flow readings. It also helped people with allergic rhinitis and atopic dermatitis experience symptom relief. Animal studies demonstrated that acupuncture reduced the infiltration of eosinophils (inflammatory white blood cells) into tissues and blocked a specific type of inflammatory cell death called pyroptosis.
For patients considering acupuncture for allergies, this research suggests it may offer a safe complementary treatment option by targeting the underlying immune mechanisms that drive allergic responses, rather than just masking symptoms. The evidence supports acupuncture's potential to reduce inflammation and improve quality of life for people with allergic conditions. If you're interested in trying acupuncture for allergies, seek care from a licensed acupuncturist with experience treating allergic conditions.
This systematic review analyzed 365 peer-reviewed studies (January 2010-January 2025) examining acupuncture's effects on mast cell-mediated allergic disorders. The review synthesized evidence from human and animal models across asthma, allergic rhinitis, dermatitis, and urticaria.
Key mechanisms identified include inhibition of mast cell degranulation with reduced histamine and IgE release, downregulation of pro-inflammatory cytokines (TNF-α, IL-4, IL-5, IL-13), and upregulation of anti-inflammatory IL-10. Molecular pathways involved suppression of NF-κB, MAPK (p38, ERK), and TLR4/MyD88 signaling cascades. Acupuncture additionally inhibited NLRP3/caspase-1-mediated pyroptosis and decreased eosinophil infiltration.
Clinical outcomes demonstrated improved pulmonary function (FEV1/PEF elevation) in asthma patients and symptomatic improvement in allergic rhinitis and atopic dermatitis. The review did not report specific effect sizes or detailed sample characteristics.
Clinical takeaway: Acupuncture demonstrates plausible mechanistic effects on mast cell regulation and inflammatory pathways underlying allergic disorders, supporting its integration as an adjunctive treatment modality. Electroacupuncture may enhance therapeutic effects through additional neuromodulation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.